Avalue Technology News Center

About to Logout

Are you sure you want to log out?



Please Login

You can explore eRMA information in service center.



Get a Quote

Select All

24 Apr. 2023

Avalue Technology Strategic Alliance with Biomdcare to Develop an AI Disease Screening System

Avalue Technology Strategic Alliance with Biomdcare to Develop an AI Disease Screening System

Taipei, Taiwan, April 24th, 2023 - Avalue Technology has announced a strategic alliance with Biomdcare, a company specializing in AI disease screening, to develop an AI disease screening system. The collaboration will utilize AI technology and HPC computing to improve the efficiency of the medical field and promote preventive treatment through early screening.

Biomdcare's AI disease screening system has been approved in Taiwan and several other countries. It offers quick and accurate screening for common diseases such as osteoporosis, cervical cancer, bladder cancer, and BRCA breast cancer. Avalue Technology has also introduced an AI-ready Intel® Xeon® medical system and edge computing system, providing the best solution for high-performance medical AI screening.

Biomdcare's osteoporosis AI screening, which has been implemented in several medical centers, has reduced the waiting time for screening from over a month to within one minute after taking an X-ray. The false positive and false negative rates are both below 10%. The osteoporosis AI screening can be used directly on an X-ray vehicle, making it convenient for corporate health checkups and rural areas. This service extends to communities and benefits more patients. Biomdcare's osteoporosis AI screening program has received formal medical certifications in Taiwan's TFDA, Vietnam, and Singapore, and has begun selling through local medical channels. The company is also currently seeking medical certifications in Thailand, Malaysia, and Japan and plans to launch sales through local medical channels by 2024.

The collaboration between the two companies combines software and hardware integration, integrating AI and HPC technologies to achieve the most topical AI and HPC technologies. In addition, the advantages of AI in medicine are highly valued. Through this collaboration, we hope to help medical personnel improve their work efficiency and promote preventive treatment in early screening to enhance the efficiency and quality of the entire medical field. The development of AI technology will bring significant changes and improvements to the medical field. For example, AI can help doctors diagnose diseases quickly and accurately, improving diagnostic accuracy and speed. It can also help researchers discover new therapies and treatment plans from vast databases, promoting the development of medical technology.

Philip Chang, the general manager of Avalue Technology, said: "We are honored to be able to collaborate with Biomdcare. This is a very important milestone. Through our AI-ready medical system and edge computing system, we can provide the most suitable computing platform for Biomdcare to support their AI disease screening system. We believe that this collaboration will accelerate the digital transformation of the medical field and bring better medical services to patients."

Omni Chang, CEO of Biomdcare, said: "We are pleased to collaborate with Avalue Technology, who has nearly 20 years of professional technology deeply rooted in the medical field and is very trustworthy. Our AI disease screening system requires high-speed computing and reliable technical support. We look forward to providing better medical services and more accurate diagnostic results for patients through this collaboration."

Finally, we look forward to this collaboration bringing more innovative technologies and applications to the medical field. Thank you for your support and attention.

[About Avalue Technology]

Avalue Technology Inc. is a company that specializes in the development of industrial computers and embedded computer-related software. The company is mainly engaged in the manufacturing of computers and peripheral equipment. Avalue has a technological advantage in the field of industrial computers and is adept at providing professional industrial computer solutions to its clients. It has a complete supply chain system in terms of product research and development, production, sales, and service. In addition, Avalue Technology has multiple subsidiaries around the world and is actively expanding its international market, providing diverse solutions to customers worldwide.

[About Biomdcare Corporation]

Biomdcare Corporation is a biomedical industry leader committed to the development of biomedical technology, intelligent hospital solutions, medical IoT, precision medical care, and medical big data science systems. The company's core philosophy is "Simple & Precise". One of Biomdcare's unique positioning products is its AI-based screening solution for women's diseases, which provides a fast, accurate, and non-invasive screening method for women's diseases and is expected to improve screening sensitivity and specificity. In addition, Biomdcare has launched multiple products, such as clinical record integration system, biomedical image platform, intelligent medical tracking system, and medical big data analysis system, to assist hospitals in improving efficiency and providing better medical care.

Media Contact:

Email: pr@avalue.com.tw


Please enter model name like EES* or *3711* in the search box.
After you click “OK” button, you can get the search result.


  • marine certified
  • marine pc


Welcome to subscribe to our e-newsletter. As long as enter your email, you can get first-hand latest news.

Subscribe Subject



Want to unsubscribe?


If you decide to unsubscribe from the newsletter, please enter your email below. We will cancel all subscription topics.

Unsubscribe Subject

Press Release


IR News

White Paper



Subscribed Successfully

Thank you for subscribing!


Unsubscribed Successfully

We will look forward to your resubscribing.


Login Required

Not clear what the message is here. Pls. advise so I can reword.